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Background. 99mTc-HMDP scintigraphy has proved its efficacy in non-invasive diagnosis
of cardiac amyloidosis (CA) and is currently interpreted according to the Perugini qualitative
assessment. Several semi-quantitative indices have been proposed to overcome inherent possible
limitations of visual grading. Our aim was to comparatively evaluate six different indices and
their diagnostic performance.
Methods. We retrospectively reviewed scintigraphy of 76 patients (53 ATTR, 12 AL, 11
LVH) who underwent diagnostic evaluation at our centre. ROC-curve analysis was performed
to identify optimal cut-off and relative diagnostic accuracy of six different indices (of which one
was proposed for the first time), both in identifying CA patients and in discriminating patients
according to their Perugini score.
Results. Heart/Whole-body ratios proved to be the most accurate (100%) in identifying CA
patients. Heart/Pelvis ratio (with soft tissue background correction) offered acceptable accu-
racy (98%), with the largest area under the curve (AUC) (0.98) in discriminating patients with
Perugini ‡ 2. Heart/Contralateral Lung ratio confirmed to be exposed to confounding back-
ground noise in case of simultaneous lung uptake. Heart/Skull ratio had the worst performance,
with six false-negative patients in ATTR identification.
Conclusion. Heart/Whole-body ratios may be robust and effective semi-quantitative
indices for the evaluation of CA by means of scintigraphy (J Nucl Cardiol 2019)
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Abbreviation
H/WBr Heart/whole-body rectangular
ROI ratio
H/WBp Heart/whole-body profile ROI ratio
H/P Heart/Pelvis Index
H/S Heart/Skull Index
H/P-bkg Heart/pelvis ratio with tissue
background correction
H/CL Heart/contralateral lung ratio
99mTc-
HMDP
99mTc-Hydroxymethylene
diphosphonate
99mTc-
DPD
99mTc-3,3-diphosphono-
1,2-propanodicarboxylic acid
99mTc-
PYP
99mTc-Pyrophosphate
Systemic amyloidosis is characterized by extracel-
lular deposition of protein-derived fibrils in different
tissues and organs, including the heart.1 Two types of
amyloid commonly infiltrate the heart: immunoglobulin
light-chain (AL) amyloid and transthyretin (TTR)
amyloid.
In recent years, total body scintigraphy with
diphosphonates, either with 99mTc-3,3-diphosphono-
1,2-propanodicarboxylic acid (99mTc-DPD), 99mTc-
Hydroxymethylene diphosphonate (99mTc-HMDP) and
99mTc-Pyrophosphate (99mTc-PYP) has gained an
important role in diagnosis of cardiac amyloidosis and in
defining the TTR subtype.2–12 Since the work by
Perugini et al., a visual score based on the strength of
cardiac uptake compared to bone uptake has become of
routine use to describe patients that undergo total body
scintigraphy in the suspect of cardiac amyloidosis.
Several semi-quantitative indices have been proposed to
describe cardiac uptake of 99mTc-diphosphonates in
cardiac amyloidosis, without agreement or clear
demonstration of superiority of one over another.6,9–11
Several reports, mainly based on planar scintigraphy,
evaluated the clinical use of a ratio between heart tracer
retention and whole-body retention (H/WB ratio),11,12
while other authors tested the accuracy of a ratio
between heart retention and skull retention (H/S
ratio).9,10 On the other hand, in the United States, fol-
lowing the work by Bokhary et al., the most commonly
used method is the heart-to-contralateral lung ratio (H/
CL), obtained by drawing a region of interest (ROI) over
the heart corrected for a contralateral ROI counts.6,13
To the best of our knowledge, no comprehensive
clinical comparison of different semi-quantitative
indices in amyloid identification has been till now
performed.
The purpose of our study is to compare, in a pop-
ulation of patients that underwent 99mTc-HMDP total
body scintigraphy during multidisciplinary evaluation
for suspected cardiac amyloidosis, already tested semi-
quantitative indices of cardiac uptake and to evaluate
their reliability and handling in routine use. Moreover,
we evaluated a new semi-quantitative index based on the
ratio between heart retention and hip retention, com-
paring its diagnostic performance to the already
published ones.
Furthermore, we aim to test if different semi-
quantitative indices were able to discriminate between
Perugini 0-1 and Perugini 2-3 visual score, a distinction
that reached a great clinical impact since the validation
of Gillmore diagnostic algorithm.14
MATERIALS AND METHODS
From the Tuscan Regional Amyloidosis Centre database,
we retrospectively evaluated all patients that underwent
99mTc-HMDP total body scintigraphy as a part of the usual
diagnostic workup to exclude or confirm a suspected cardiac
amyloidosis. All patients underwent physical examination,
electrocardiogram (ECG), transthoracic echocardiography and
blood tests including NT-proBNP, serum and urinary
immunofixation and serum-free light chain measurement. In
case of inconclusive results patients underwent cardiac MRI.
All patients gave written informed consent for their
clinical records to be used for research purposes, in accordance
with Institutional Review Board guidelines.
Diagnosis of Amyloidosis and Cardiac
Involvement Definition
Diagnosis of light-chain (AL) amyloidosis was made by
biopsy of abdominal fat pad or biopsy of an involved organ,
which demonstrated the typical Congo Red birefringence when
viewed under polarized light. All positive biopsies demon-
strated typical Congo Red birefringence under polarized light
and staining by anti-k or anti-k light-chain antibodies, com-
bined with elevated serum or urine levels of the corresponding
monoclonal light chain.
Diagnosis of TTR amyloidosis was made invasively by
staining of tissue biopsy with anti-TTR antibodies (irrespec-
tively of cardiac uptake at bone-tracer scintigraphy), or
according to the non-invasive algorithm suggested by Gillmore
and colleagues 14 whenever a positive tissue biopsy was not
available: that required a combination of a Perugini grade 2 or
3 bone-tracer cardiac uptake, together with the absence of a
detectable serum/urinary monoclonal protein, in a patient with
echocardiogram and/or MRI suggestive of cardiac
amyloidosis.
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Diagnosis of mutated (ATTRm) or wild-type (ATTRwt)
amyloidosis was made according to presence or absence of
mutation at genotyping.
Diagnosis of cardiac involvement in systemic amyloidosis
was made according to the International Society of Amyloi-
dosis criteria.15
Patients were considered to have left ventricular hyper-
trophy (LVH) not related to amyloid infiltration if they had a
negative cardiac biopsy or at least two negative non-cardiac
biopsies with no suggestive signs of cardiac amyloidosis at
non-invasive imaging evaluation (99mTc-HMDP total body
scintigraphy, echocardiography and MRI), in the absence of
amyloidogenic mutation at genotyping.
Standard and Tissue Doppler Imaging
Echocardiography
Patients were referred to our laboratory for echocardio-
graphic study. Echocardiography was performed using a Vivid
9 System (Vingmed, General Electric, Horten, Norway)
equipped with a 3S probe. According to the standards of the
American Society of Echocardiography,16 the following
parameters were assessed: end-diastolic thickness of interven-
tricular septum (IVS) and LV posterior wall (PW), LV end-
diastolic and end-systolic volumes (LVEDV and LVESV,
respectively), ejection fraction (estimated with the biplane
Simpson method), and tricuspid annular plane systolic excur-
sion (TAPSE). We also evaluated pulsed tissue Doppler
imaging-derived early diastolic peak velocity of mitral annulus
(E’), to perform the E/E’ ratio as an index of LV filling
pressure.
99mTc-HMDP Scintigraphy
All patients had 99mTc-HMDP whole-body scintigraphy
(HMDP-TB). 99mTc-HMDP was prepared from the commer-
cial kit (OSTEOCIS) following the prescriptions of the
manufacturer. All the preparations were tested for total
hydrolysed and free 99mTc (\ 5%) and for radiochemical
purity ([ 95%). Each patient received intravenous 700-
740 MBq of 99mTc-HMDP and a whole-body scan (anterior
and posterior projections) was performed 150 minutes later in
a 256*1024 matrix. Images were acquired in two different
gamma cameras, Discovery (GE) and Ecam (Siemens), using
low energy, high-resolution collimators and an appropriate
scan speed to reach over 2.000.000 count. Each scintigraphy
was evaluated by Perugini visual score as previously
published.2
Semi-quantitative Analysis
In all patients, 99mTc-HMDP cardiac uptake was
assessed using the following semi-quantitative simplified
indices: Heart/whole-body rectangular ROI ratio (H/WBr);
Heart/whole-body profile ROI ratio (H/WBp); Heart/Pelvis
Index (H/P), Heart/pelvis ratio with tissue background
correction (H/P-bkg), Heart/Skull Index (H/S), and Heart/
Contralateral Lung ratio (H/CL) (Figure 1).
• Heart/Whole-Body rectangular ROI ratio (H/
WBr): the following ROI were drawn (anterior
projection): a rectangular one embracing the whole-
body profile; three anatomical ROI traced along the
bladder and the two kidneys, and a heart ROI. Tracer
uptake was quantified as total counts for each ROI.
The semi-quantitative index was calculated as fol-
lows:
heart ROI
WBrect:ROI bladder ROIþ kidneys ROIsð Þ
• Heart/Whole-Body profile ROI ratio (H/WBp): it
is analogous to the previous index, with the exception
that WB ROI is drawn along the anatomical body
profile, rather than along a rectangular simplified
shape.
• Heart/pelvis ratio (H/P): the following ROI were
drawn: (anterior projection) a heart ROI and (poste-
rior projection) an anatomical ROI around the pelvis
and the sacrum profile. Tracer uptake was quantified
as mean counts for each ROI. The semi-quantitative
index was calculated as follows:
heart ROI
pelvis Rol
• Heart/pelvis ratio with tissue background
correction (H/P-bkg): the following ROI were
drawn (anterior projection): a simplified circular
ROI around the heart and a specular contralateral
ROI in the right hemithorax (bkg1); (posterior
projection) a simplified ovalar ROI around a sacro-
iliac joint; a simplified little rectangular ROI over the
abdomen (bkg2). Tracer uptake was quantified as
mean counts for each ROI. The semi-quantitative
index was calculated as follows:
heart ROI bkg1
Sacroiliac joint ROI bkg2
• Heart/skull ratio (H/S): the following ROI were
drawn: two heart ROI (anterior and posterior
projection) and two simplified rectangular ROI
around the skull (anterior and posterior projection).
Tracer uptake was quantified as mean counts for each
ROI. The semi-quantitative index was calculated as
follows:
arithmeticmean heart ROIs
arithmeteicmean skull ROIs
• Heart/contralateral lung (H/CL): the following ROI
were drawn: a simplified circular ROI around the
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heart and a specular contralateral ROI in the right
hemithorax (contralateral lung; CL) (anterior
projection). Tracer uptake was quantified as mean
counts for each ROI. The semi-quantitative index was
calculated as follows:
heart ROI
CLROI
STATISTICAL ANALYSIS
Continuous variables are expressed as mean values
and standard deviation, and categorical variables as
frequencies and percentages. Multiple comparisons for
continuous variables were performed with ANOVA
followed by Scheffe` test for post hoc analyses.
For each heart-retention semi-quantitative index,
sensitivity and specificity were defined by ROC curves
analysis, grouping the patients into two categories:
ATTR, as positive and AL and non-amyloidosis, as
negative. Moreover, we defined for each semi-quantita-
tive index, by ROC curve analysis, the best cut-off value
able to discriminate Perugini 0–1 visual score from
Perugini 2–3 visual score.
All statistical analyses and comparisons were per-
formed with SPSS 20 Version IBM Package and we
considered statistical significance a P value\ 0.05.
All statistical analyses and comparisons were per-
formed with SPSS 20 Version IBM Package and we
considered statistical significance a P value\ 0.05.
To check for consistency of measures obtained by
semi-quantitative scoring, we performed a formal anal-
ysis of reproducibility (inter-observer variability) and
repeatability (intra-observer variability) on a randomly
selected sample of 20 patients; results were compered by
mean of Intraclass correlation coefficient (ICC) with a
cut-off of 0.90.
RESULTS
From Tuscan Regional Amyloid Center database
retrospective analysis, we identified 76 subjects that
underwent 99mTc-HMDP scintigraphy during evalu-
ation for suspected cardiac amyloidosis. At the end
of multidisciplinary assessment, 12 patients were
affected by AL cardiac amyloidosis, 53 patients were
affected by TTR cardiac amyloidosis (16 ATTRm,
37 ATTRwt) while 11 patients showed left ventric-
ular hypertrophy not related to amyloidosis. In all
AL patients, biopsy site was abdominal fat pad. In
TTR amyloidosis, positive biopsy was present in
20/53 (38%) patients and the positive biopsy site
was abdominal fat in 12 patients and myocardium
in 8.
Twenty-six patients (5 AL, 6 ATTRm, 4 ATTRwt
and 11 LVH) were part of an already published
multicentre analysis.11 Demographic and clinical char-
acteristics of three groups are reassumed in Table 1.
Figure 1. Representation of ROIs’ drawing method for index calculation. A Heart/whole-body
rectangular ROI ratio (H/WBr); B Heart/Whole-Body profile ROI ratio (H/WBp); C Heart/Pelvis
Index (H/P); D Heart/Skull Index (H/S); E Heart/pelvis ratio with tissue background correction (H/
P-bkg); F Heart/contralateral lung ratio (H/CL).
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At 99mTc-HMDP scintigraphy only one out of 12
AL patients showed a Perugini 1 heart retention while
all patients with TTR cardiac amyloidosis demonstrated
heart uptake, with 5 Perugini visual score 1, 20 Perugini
2 and 28 Perugini 3 (Table 1). No cardiac uptake was
evidenced in patients with LVH not due to amyloid
deposition. Considering five patients with grade 1 scan
in TTR group, a Perugini grade 2–3 cardiac uptake on a
99mTc-HMDP scintigraphy showed a 91% sensitivity
and a 100% specificity.
As reported in Table 1, all the semi-quantitative
assessment methods showed significantly higher values
in ATTR patients without significant differences
between AL and LVH patients.
For each semi-quantitative method, ROC curve
analysis was performed to identify the best cut-off value
to achieve the greatest accuracy in ATTR identification.
As reported in Table 2, H/WB indices (H/WBr and
H/WBp) reached a 100% accuracy in ATTR
identification, irrespectively of the method used to
trace the whole-body ROI, while H/CL showed a
slightly worse performance due to a false-negative
patient that showed a clear HMDP lung retention. On
the other hand, all the parameters based on a ratio
between heart and a bone structure (H/S; H/P; H/P-
bkg) showed a diagnostic accuracy below the expec-
tation with more misclassified patients compared to H/
WB and H/CL ratios. In fact, H/P-bkg and H/P
misclassified 2 and 3 patients, respectively, while H/S
reached the worst performance misidentifying six false-
negative patients.
Results of a subgroup analysis of semi-quantitative
method according to Perugini visual score grading in the
whole population are reassumed in Table 3.
All semi-quantitative indices showed significantly
different values between Perugini 0 and Perugini C 1,
with the exception of H/S, that showed no significantly
different values between Perugini 0 and Perugini 1.
Table 1. Clinical and biohumoral characteristics
LVH (n = 11) AL (n = 12) TTR (n = 53) P
Age, years 78 ± 6 72 ± 13 78 ± 7 .07
Gender M/F 10/1 8/4 43/6 .204
NT-proBNP, ng/ml 3352 ± 2677 6871 ± 6405 4773 ± 4046 .241
IVS, mm 14.7 ± 2.9 16.6 ± 2.1 17.3 ± 2.9 .015
LVPW, mm 13.3 ± 1.5 13.8 ± 2.4 16.1 ± 2.7** .003
LVEDV, ml 95 ± 33 97 ± 30 74 ± 30 .384
LVESV, ml 42 ± 23 52.5 ± 26.1 30.1 ± 13.6 .138
EF% 55 ± 9 59 ± 7 48 ± 12 .053
E/E’ 15 ± 6 16 ± 8 17 ± 6 .610
TAPSE, mm 19 ± 4 17 ± 3 16 ± 4 .345
Perugini score .0001
Perugini 0 11 11 0
Perugini 1 – 1 5
Perugini 2 – – 20
Perugini 3 – – 28
H/WBp 1.8 ± 0.7 2.2 ± 0.5 6.0 ± 1.6* .0001
H/WBr 1.8 ± 0.7 2.2 ± 0.5 5.9 ± 1.6* .0001
H/P 0.9 ± 0.2 0.85 ± 0.1 1.8 ± 0.42* .0001
H/S 1.6 ± 0.3 1.5 ± 0.3 2.8 ± 0.8* .0001
H/P-bkg 0.4 ± 0.3 0.3 ± 0.1 0.9 ± 0.4* .0001
H/CL 1.0 ± 0.1 1.1 ± 0.1 1.8 ± 0.3* .0001
AL, Light-chain amyloidosis; EF, ejection fraction; H/CL, Cardiac Uptake/Contralateral Lung Index; H/P-bkg, Heart/pelvis ratio with
tissue background correction; H/P, Heart/Pelvis Index, H/S, Heart/Skull Index; H/WBr, Heart/whole-body rectangular ROI ratio;
H/WBp, Heart/whole-body profile ROI ratio; IVS, interventricular septum; LVEDV, left ventricular end-diastolic volume; LVESV, left
ventricular end-systolic volume; LVH, left ventricular hypertrophy; PW, posterior wall; TAPSE, Tricuspid Annular Plane Systolic
Excursion; TTR, transthyretin amyloidosis
Post hoc analysis *P\ .05 TTR vs others
**P\ .05 TTR vs LVH
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H/WB indices showed significantly different values
between Perugini 0 and Perugini 1 and, between
Perugini 1 and Perugini 2–3, while H/CL showed a
significant difference between Perugini 0 and Perugini 1
but no significant difference between Perugini 1 and
Perugini 2. Surprisingly, no semi-quantitative method
was able to show a significant difference between
Perugini 2 and Perugini 3 subgroups. ROC curve
analysis identified cut-off values able to discriminate
subjects with Perugini 2–3 versus Perugini 0–1
(Table 4). All the methods reached an acceptable sensi-
tivity and specificity, with H/P-bkg that reached the
highest area under the curve (AUC) followed by H/WB
(both ‘‘rectangular’’ and ‘‘profile’’) while H/S and H/P
had the lowest AUC.
Analysis of inter-observer and intra-observer vari-
ability is reported in Table 5. H/CL showed the
greatest repeatability and reproducibility, despite inter-
observer analysis of data resulted in re-classification
of one patient. H/WB indices, both rectangular and
profile, showed comparable results, with adequate
inter- and intra-observer variability. When compared
to H/CL, they showed less consistency, but still
resulted in higher robustness: no patient was re-
classified after inter-observer analysis of data, without
major consequences on diagnostic performance.
Higher variability is somehow an expected finding,
since H/WB indices depend upon selection of multiple
ROIs, while H/CL relies on just two ROIs, thus
reducing the place for measurement changes. Of note,
H/S had the highest variability both at inter- and intra-
observer analysis; such a finding may result from a
combination of both the number of ROIs (in anterior
and posterior projection) required, and the difficult
definition of skull ROI using a rectangular contour.
Despite high repeatability, H/P-bkg was affected by
lower inter-observer reproducibility of measurement.
DISCUSSION
To the best of our knowledge, this is the first
research comparing several 99mTC-HMDP total body
scintigraphy semi-quantitative indices in patients under-
going multidisciplinary evaluation for suspected cardiac
amyloidosis.
Our data confirm that patients with TTR cardiac
amyloidosis show 99mTc-HMDP heart retention with
commonly a Perugini 2–3 visual score, while AL
amyloidosis less often shows heart retention and, at
least in our population, presents with lower visual score.
Moreover, our data show that all the semi-quantitative
parameters are significantly increased in the TTR
cardiac amyloid subgroup. On the other hand, different
semi-quantitative heart retention indices showed differ-
ent accuracy in cardiac TTR amyloid identification
(Table 2). The ratio between heart retention and whole-
body retention showed the best accuracy irrespectively
of the method used to identify the whole-body ROI. This
finding is consistent with our previous work, where a
cut-off of 3.3 at H/WB showed a 100% accuracy in
cardiac ATTR identification.11 H/S ratio showed unac-
ceptable sensitivity with six patients with TTR cardiac
amyloidosis misclassified as false negative, while the
newly proposed heart to pelvis ratio, showed an inter-
mediate accuracy with better results if corrected by
background. H/CL demonstrated a good accuracy in
cardiac TTR amyloid identification, with only one false-
negative result. Re-analysis of 99mTc-HMDP scintigra-
phy of this subject showed a clear lung retention that, as
previously reported by our group, could have reduced
the ratio between heart and lung resulting in a
misidentification.17
H/S lowest sensitivity could be reasonably
explained by two factors: the presence of increased
skull uptake and/or a low heart uptake. In fact, skull and
Table 3. Semi-quantitative index values by Perugini visual score grading
Perugini 0 N = 22 Perugini 1 N = 6 Perugini 2 N = 20 Perugini 3 N = 28 P<
H/WBp 1.9 ± 0.6 * 4.3 ± 0.7§ 5.9 ± 1.7 6.4 ± 1.5 .0001
H/WBr 2.0 ± 0.6* 4.3 ± 0.6§ 5.8 ± 1.8 6.3 ± 1.5 .0001
H/P 0.87 ± 0.15* 1.6 ± 0.6 1.8 ± 0.41 1.9 ± 0.4 .0001
H/S 1.6 ± 0.3 1.9 ± 0.6 2.7 ± 0.7£ 3.0 ± 0.7£ .0001
H/P-bkg 0.2 ± 0.5* 0.4 ± 0.2§ 0.8 ± 0.4 1.0 ± 0.4 .0001
H/CL 1.0 ± 0.1* 1.5 ± 0.2 1.8 ± 0.4 1.9 ± 0.3& .0001
H/CL, cardiac uptake/contralateral lung; H/P-bkg, Heart/pelvis ratio with tissue background correction; H/P, Heart/Pelvis Index,
H/S, Heart/Skull Index; H/WBr, Heart/whole-body rectangular ROI ratio; H/WBp, Heart/whole-body profile ROI ratio
Post hoc analysis: *P\ .05 for Perugini 0 vs others; §P\ .05 for Perugini 1 vs others; £P\ .05 vs Perugini 0 and Perugini 1;
&P\ .05 for Perugini 3 vs Perugini 0 and Perugini 1
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maxillofacial bones show highly variable retention of
phosphonates; its enhancement, for instance in hyper-
ostosis (a common paraphysiological condition) and
sinusitis, increases the denominator of the ratio, reduc-
ing the value of the index. Second, among H/S false-
negative patients, we observed a prevalence of Perugini
1 patients, that showed lower value of heart uptake.
On the other hand, the better accuracy of H/P-bkg
compared to H/P could be explained by tissue back-
ground correction that minimizes the undesired effects
of aspecific tracer distribution and background noise.
As recently suggested by Rapezzi and coauthors,18
while different bone tracers (99mTc-PYP, 99mTc-HMDP
and 99mTc-DPD) seem to be interchangeable for the
diagnosis of cardiac ATTR, bone tracers are not equally
able to image non-cardiac TTR amyloidosis. Hutt and
colleagues demonstrated that a consistent percentage of
patients with TTR amyloidosis (70/77) show a clear
99mTc-DPD muscular retention, particularly in gluteal,
shoulder region and in the abdominal wall.5 These data
have been confirmed by a larger study by the same group
in which authors demonstrated, in a cohort of TTR
amyloidosis patients, that soft tissue to femur ratio (a
reasonable marker of extracardiac amyloid infiltration)
was significantly different between each Perugini grade of
99mTc-DPD scan, progressively increasing from grade 1
to grade 3 visual score.19 On the other hand, Sperry and
coauthors reported that no muscular retention could be
evidenced in a cohort of 57 patients with TTR cardiac
amyloidosis, in an advanced phase of the disease, who
underwent 99mTc-PYP scintigraphy.20 In our cohort, few
patients (1 (5%) AL patient; 5 (9%) TTR patients, 0 LVH
patients) showedmuscular uptake, suggesting that HMDP
acts at an intermediate level between PYP and DPD
regarding muscular tracer retention. Therefore, in our
cohort the good accuracy reached by H/WBr and H/WBp
in cardiac TTR amyloidosis identification could be also
explained by the lack of diffuse muscular tracer retention.
Conversely, the major technical concern about H/WB
ratio is the overlap between heart and sternum, which
could lead to an overestimation of heart retention.
Otherwise the determinants of total counts measured in
H/WB indices (administered dose, time of acquisition and
urinary radiotracer excretion) affects proportionally car-
diac uptake and WB retention contributing to the
robustness of these indices.
Heart to bones ratios achieved a worse accuracy in
cardiac TTR amyloid identification especially in Perug-
ini 1 patients, with false-negative result in one or more
heart-to-bones indices in 80% of cases. This lack of
accuracy could be explained by a combination of lower
cardiac uptake and bone hyperactivity, which could
result in lower values, and consequently in false-nega-
tive identification.T
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As previously reported, semi-quantitative method
could be a useful tool to correctly identify patients with
TTR cardiomyopathy. Moreover, semi-quantitative
index could be a help to correctly objectify heart
retention and correctly classify the patient in the right
Perugini grade.
Since the seminal work by Gillmore and coau-
thors,14 a correct identification of Perugini grade has
reached a great clinical impact, especially in the hedge
between Perugini 1 and Perugini 2. In fact, in the
absence of a monoclonal gammopathy, a Perugini
grade C 2 at scintigraphy allows a diagnosis of TTR
cardiac amyloidosis, avoiding endomyocardial biopsy
and its inherent risks. Our research demonstrated that, on
a subgroup analysis according to Perugini visual score,
semi-quantitative methods showed unexpected and
heterogeneous results.
Surprisingly H/CL does not show significantly
different values between Perugini 1 and Perugini 2
patients. Moreover, no semi-quantitative index showed
significantly different values between patients with
Perugini 2 and Perugini 3 visual score. On ROC curve
analysis H/WBr and H/P-bkg showed an acceptable ac-
curacy in discrimination between Perugini 0–1 and
Perugini 2–3. Unfortunately, as previously discussed,
despite a good performance in Perugini 1 vs Perugini 2–
3 discrimination, H/P-bkg shows a slightly lower accu-
racy in identifying cardiac TTR amyloidosis patients.
Therefore, our observations as a whole would
suggest that H/WB ratios (both profile and rectangular
ROI) could be a reliable semi-quantitative method in the
interpretation of 99mTC-HMDP scintigraphy, since they
achieved the best performance in correctly identifying
cardiac TTR amyloidosis, while at the same time
showed a good diagnostic accuracy in correctly classi-
fying Perugini 1 vs Perugini 2–3 subgroups, a
discrimination with major clinical implication;
furthermore H/WB ratios allowed for a good repeata-
bility and reproducibility, with the highest robustness of
diagnostic performance. Due to the comparable results
in HR/WB ratios, irrespectively to the method used to
trace the whole-body ROI, rectangular WB ROI could
be recommended as the easiest and time saving tech-
nique to evaluate WB tracer retention.
NEW KNOWLEDGE GAINED
In a cohort of patients that underwent 99mTc-
HMDP in a clinical suspicious of cardiac amyloidosis,
H/WB (rectangular or profile) ratios are the best semi-
quantitative indices able to correctly identify patients
with TTR cardiac amyloidosis. H/CL seems to be less
accurate mainly in case of simultaneous heart and lung
bone tracer retention.
In a real-world setting, H/WB could be the semi-
quantitative methods of choice to help clinicians to
correctly identify TTR cardiac amyloidosis patients and
differentiate between Perugini 1 and Perugini 2–3, a
discrimination with major clinical implication.
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